San Diego, California based medical device manufacturer DexCom, Inc. DXCM late on Thursday released financial results that sent the company's stock price plummeting during after hours trading.
DexCom, Inc reported a 3rd quarter net loss of 23 cents per share, on revenue of $10.78 million.
A poll of analysts conducted by Thomson Reuters showed an average Wall Street estimate of an expected loss of 18 cents per share, on revenue of $13.14 million.
DexCom, Inc. (DXCM) ended the Thursday trading session at $13.91 per share, then fell 20.1% to $11.11 during after hours trading. Analysts covering the company's stock have a consensus price target of $14.72 per share.
Read more from Benzinga's Company news.
Market News and Data brought to you by Benzinga APIs© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in